Partner and CSO, B2S Life SciencesBiography
Dr. Bowsher’s career in the pharmaceutical/biotechnology and CRO industries has spanned 4½ decades, including 3 decades at the Lilly Research Labs and nearly 2 decades as a consultant and an advisor in the CRO industry. He is a recognized thought-leader in the areas of bioanalytical methods development for regulatory-compliant bioanalysis, ADME and immunogenicity assessments of biotherapeutics. He received his M.S. and Ph.D. degrees in Biochemistry & Molecular Biology at the Indiana University School of Medicine (Indianapolis, IN).
Currently, he is Partner and CSO at B2S Life Sciences™ (www.B2SLifeSciences.com), a biotechnology drug enablement company located in Franklin, IN that specializes in the generation and life-cycle management of custom biological reagents, ligand binding assay development and ADME, and data analytics to support biotherapeutic drug development.In 2004, Dr. Bowsher was elected as an AAPS Fellow and was given an AAPS Presidential citation in 2008 for his efforts to establish educational training programs for supporting Biotech R&D. In 2011, Dr. Bowsher received the AAPS BIOTEC Section distinguished service award.